Pablo Corral

1.8k total citations
42 papers, 272 citations indexed

About

Pablo Corral is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Pablo Corral has authored 42 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Surgery, 17 papers in Cardiology and Cardiovascular Medicine and 13 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Pablo Corral's work include Lipoproteins and Cardiovascular Health (32 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers) and Cancer, Lipids, and Metabolism (6 papers). Pablo Corral is often cited by papers focused on Lipoproteins and Cardiovascular Health (32 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers) and Cancer, Lipids, and Metabolism (6 papers). Pablo Corral collaborates with scholars based in Argentina, Australia and Colombia. Pablo Corral's co-authors include Kausik K. Ray, Laura Schreier, Enrique Morales, Stephen J. Nicholls, Carlos A. Aguilar‐Salinas, Rita A. Gómez‐Díaz, Antonio J. Vallejo‐Vaz, Juan Patricio Nogueira, Walter Massón and Augusto Lavalle Cobo and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Pablo Corral

37 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pablo Corral Argentina 8 154 93 69 52 48 42 272
Julia Brandts Germany 11 211 1.4× 82 0.9× 82 1.2× 46 0.9× 52 1.1× 30 333
Delia Silverio United States 9 123 0.8× 82 0.9× 59 0.9× 81 1.6× 38 0.8× 10 301
Ying Hao China 13 87 0.6× 49 0.5× 35 0.5× 77 1.5× 33 0.7× 28 290
E Papakonstantinou Greece 8 133 0.9× 72 0.8× 60 0.9× 38 0.7× 37 0.8× 14 301
Zammy Fairhurst-Hunter United Kingdom 4 109 0.7× 105 1.1× 45 0.7× 49 0.9× 37 0.8× 7 283
Alessandra M. Campos‐Staffico Brazil 10 111 0.7× 66 0.7× 73 1.1× 36 0.7× 14 0.3× 29 276
Giovanni Pigna Italy 8 145 0.9× 165 1.8× 165 2.4× 44 0.8× 73 1.5× 9 333
Grace Stewart United Kingdom 6 189 1.2× 151 1.6× 47 0.7× 37 0.7× 75 1.6× 10 334
Jakub J. Regieli Netherlands 8 154 1.0× 43 0.5× 99 1.4× 59 1.1× 32 0.7× 13 288
Simone Sorkin Arazi Brazil 10 163 1.1× 63 0.7× 16 0.2× 59 1.1× 64 1.3× 15 282

Countries citing papers authored by Pablo Corral

Since Specialization
Citations

This map shows the geographic impact of Pablo Corral's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Corral with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Corral more than expected).

Fields of papers citing papers by Pablo Corral

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Corral. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Corral. The network helps show where Pablo Corral may publish in the future.

Co-authorship network of co-authors of Pablo Corral

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Corral. A scholar is included among the top collaborators of Pablo Corral based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Corral. Pablo Corral is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Corral, Pablo, et al.. (2025). Inhibition of angiopoietin-like protein 3 as a target for managing hypertriglyceridemia. Current Opinion in Endocrinology Diabetes and Obesity. 33(2). 77–83. 1 indexed citations
2.
Corral, Pablo, et al.. (2025). Impact of SGLT2 Inhibitors on Lipoproteins in Type 2 Diabetes. Current Diabetes Reports. 25(1). 16–16. 3 indexed citations
3.
Schreier, Laura, et al.. (2024). Temporal variability of Lp(a) in clinically stable patients: Implications for cardiovascular risk assessment. Medicina Clínica. 163(9). 436–441. 2 indexed citations
4.
Massón, Walter, Pablo Corral, Juan Patricio Nogueira, & Augusto Lavalle Cobo. (2024). Applicability of Artificial Intelligence in the Field of Clinical Lipidology: A Narrative Review. Journal of Lipid and Atherosclerosis. 13(2). 111–111. 2 indexed citations
5.
Massón, Walter, et al.. (2024). Inhibitors of apolipoprotein C3, triglyceride levels, and risk of pancreatitis: a systematic review and meta-analysis. Reviews in Endocrine and Metabolic Disorders. 25(5). 817–825. 6 indexed citations
6.
Corral, Pablo, María Gabriela Matta, Carlos A. Aguilar‐Salinas, et al.. (2024). Lipoprotein(a) throughout life in women. SHILAP Revista de lepidopterología. 20. 100885–100885. 8 indexed citations
7.
Schreier, Laura, et al.. (2024). Temporal variability of Lp(a) in clinically stable patients: Implications for cardiovascular risk assessment. Medicina Clínica (English Edition). 163(9). 436–441.
8.
Renna, Nicolás, et al.. (2024). Recommendations for the management of patients with type 2 diabetes at hospital discharge after an ischaemic cardiovascular event. Hipertensión y Riesgo Vascular. 41(4). 251–259. 1 indexed citations
9.
Massón, Walter, et al.. (2023). Lipoprotein(a) and heart failure: a systematic review. Heart Failure Reviews. 28(6). 1307–1314. 4 indexed citations
10.
Cobo, Augusto Lavalle, et al.. (2023). Ethnic/Racial and Geographic Disparities on Major Cardiovascular Events in Glucagon Like Peptide-1 receptor Agonists Trials: A Meta-Analysis. Current Problems in Cardiology. 48(11). 101940–101940. 5 indexed citations
11.
Massón, Walter, Pablo Oberti, Mariano Falconi, et al.. (2023). High lipoprotein(a) levels and mitral valve disease: A systematic review. Nutrition Metabolism and Cardiovascular Diseases. 33(5). 925–933. 3 indexed citations
12.
Massón, Walter, et al.. (2023). Plasma Lipoprotein(a) Levels in Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis. High Blood Pressure & Cardiovascular Prevention. 30(4). 305–317. 6 indexed citations
13.
Massón, Walter, et al.. (2023). Elevated Lipoprotein(a) Levels and Atrial Fibrillation: A Systematic Review. Journal of Lipid and Atherosclerosis. 12(3). 267–267. 1 indexed citations
14.
Matta, María Gabriela, et al.. (2023). Hipertrigliceridemia grave en Argentina: prevalencia y características clínicas. Revista Argentina de Cardiología. 149–152.
15.
Massón, Walter, et al.. (2023). Relationship Between Lipoprotein(a) Levels and Cardiovascular Outcomes in Postmenopausal Women: A Systematic Review. Current Problems in Cardiology. 48(4). 101589–101589. 7 indexed citations
16.
Massón, Walter, et al.. (2022). Effect of Yerba Mate (Ilex paraguariensis) on Lipid Levels: A Systematic Review and Meta-Analysis. Plant Foods for Human Nutrition. 77(3). 353–366. 5 indexed citations
17.
Santos, Raúl D., Alberto Lorenzatti, Pablo Corral, et al.. (2021). Challenges in familial chylomicronemia syndrome diagnosis and management across Latin American countries: An expert panel discussion. Journal of clinical lipidology. 15(5). 620–624. 5 indexed citations
18.
Corral, Pablo, et al.. (2020). Fenotipo de hipercolesterolemia familiar definitivo con estudio genético negativo en Argentina. Archivos de cardiología de México. 90(2). 151–157. 1 indexed citations
19.
Ray, Kausik K., Pablo Corral, Enrique Morales, & Stephen J. Nicholls. (2019). Pharmacological lipid-modification therapies for prevention of ischaemic heart disease: current and future options. The Lancet. 394(10199). 697–708. 68 indexed citations
20.
Corral, Pablo, Ana Margarida Medeiros, Juan P. Bustamante, et al.. (2017). Preliminary spectrum of genetic variants in familial hypercholesterolemia in Argentina. Journal of clinical lipidology. 11(2). 524–531. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julia Brandts Breakdown of academic impact, for papers by Delia Silverio Breakdown of academic impact, for papers by Ying Hao Breakdown of academic impact, for papers by E Papakonstantinou Breakdown of academic impact, for papers by Zammy Fairhurst-Hunter Breakdown of academic impact, for papers by Alessandra M. Campos‐Staffico Breakdown of academic impact, for papers by Giovanni Pigna Breakdown of academic impact, for papers by Grace Stewart Breakdown of academic impact, for papers by Jakub J. Regieli Breakdown of academic impact, for papers by Simone Sorkin Arazi
Rankless by CCL
2026